Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Furqaan Ahmed

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Gastroenterology|October 9, 2010
Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trialFurqaan Ahmed, Ira M Jacobson, Jorge L Herrera, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
Gastroenterology|December 3, 2015
A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal NeoplasmsHan-Mo Chiu, Jessica Y L Ching, Kai Chun Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2020
Development and Validation of the Asia-Pacific Proximal Colon Neoplasia Risk ScoreMartin C S Wong, Rungsun Rerknimitr, Khean Lee Goh, et al.
The American Journal of Gastroenterology|March 16, 2016
Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific RegionsMartin C S Wong, Jessica Y L Ching, Han-Mo Chiu, et al.
The American Journal of Gastroenterology|November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis CIra M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Clinical Gastroenterology|October 9, 2010
Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trialFurqaan Ahmed, Ira M Jacobson, Jorge L Herrera, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
Gastroenterology|December 3, 2015
A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal NeoplasmsHan-Mo Chiu, Jessica Y L Ching, Kai Chun Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 11, 2020
Development and Validation of the Asia-Pacific Proximal Colon Neoplasia Risk ScoreMartin C S Wong, Rungsun Rerknimitr, Khean Lee Goh, et al.
The American Journal of Gastroenterology|March 16, 2016
Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific RegionsMartin C S Wong, Jessica Y L Ching, Han-Mo Chiu, et al.
The American Journal of Gastroenterology|November 11, 2005
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis CIra M Jacobson, Stevan A Gonzalez, Furqaan Ahmed, et al.
Pageof 2